FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/03/023735 [Registered on: 03/03/2020] Trial Registered Prospectively
Last Modified On: 02/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   To find out association of Lipopotein(a)levels and heart problems in narrowed blood carrying artery due to plaque build up on the artery walls  
Scientific Title of Study   Lipoprotein (a) Levels and Major Adverse Cardiac Events in Patients with Established Atherosclerotic Cardiovascular Disease  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Navaneeth 
Designation  PhD scholar 
Affiliation  Kasturba medical college and hospital,MAHE, Manipal 
Address  department of cardiology kasutba medical college and hospital MAHE ,manipal

Udupi
KARNATAKA
576104
India 
Phone  8970892464  
Fax    
Email  naviamin7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tom Devasia 
Designation  professor and head 
Affiliation  Kasturba medical college and hospital,MAHE, Manipal 
Address  department of cardiology kasutba medical college and hospital MAHE ,manipal

Udupi
KARNATAKA
576104
India 
Phone  9448158508  
Fax    
Email  gt.cardiology@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Navaneeth 
Designation  PhD scholar 
Affiliation  Kasturba medical college and hospital,MAHE, Manipal 
Address  department of cardiology kasutba medical college and hospital MAHE ,manipal

Udupi
KARNATAKA
576104
India 
Phone  8970892464  
Fax    
Email  naviamin7@gmail.com  
 
Source of Monetary or Material Support  
kasturba medical college and hospital 
 
Primary Sponsor  
Name  Manipal academy of Higher education 
Address  kasturba medical college and hospital madhva nagar,maniapl-576104 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Navaneeth  kasturba Hospital  Department of cardiology, OPD block,room no :36 madhva nagar manipal-576104
Udupi
KARNATAKA 
8970892464

naviamin7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
kastuba medical college and kasturba hospital institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I219||Acute myocardial infarction, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
2. History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit 
 
ExclusionCriteria 
Details  1.Patients currently enrolled in clinical
studies with investigational drugs
2.Patients with proven Psychiatric illness on
medications
3.Patients with chronic liver disease
4.Pregnant women
5.Terminal malignancy patients 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Association of elevated Lp(a) in established cardiovascular disease (CVD)
2.Identifying relationship between raised levels of Lp(a) and other biochemical parameters including lipid profile among the sub group population with established ASCVD
3.Identifying association of anthropometric parameters with Lp(a) levels in patients with established ASCVD
4.Co-relation between Lp(a) and MACE rate on 18 months follow up of patients with documented ASCVD on standard medical therapy including statins
 
3 years 
 
Secondary Outcome  
Outcome  TimePoints 
Association of elevated Lp(a) in established cardiovascular disease (CVD)
• Co-relation between Lp(a) and MACE rate on 18 months follow up of patients with documented ASCVD on standard medical therapy including statins
 
3years 
 
Target Sample Size   Total Sample Size="600"
Sample Size from India="600" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/03/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Lipoprotein(a) has been considered a cardiovascular risk factor for many years. Although prospective, randomized, controlled outcomes studies have not been conducted, epidemiological, genome-wide association and Mendelian randomized controlled study data provide supporting evidence for a role of Lp(a) in CVD .
however this trail help to understand the association of Lp(a) and major adverse cardiac events related to the elevated Lp(a) levels in atherosclerotic cardiovascular disease.
 
Close